Mark Painter
Mark Painter is CEO of PRS Urology SC in Denver.
‘I can’t keep up’: Pay cuts, prior authorization take their toll
QRUR: What is it, and why should you care?
"We strongly recommend that you obtain your practice QRUR regardless of your practice size and learn more about the report," write Ray Painter, MD, and Mark Painter.
Medicare Part B drug billing revisited
Medicare Part B drug billing revisited
It’s time to revisit billing for Medicare Part B drugs. A proposed demonstration project that every urologist should be aware of, a change in the “brown bag” rules since our last publication, and a continued loss of income by many offices are making the purchase and delivery of drugs less palatable for urology offices.
How to code for pelvic lymphadenectomy
How to code for pelvic lymphadenectomy
The Painters also answer a question about billing for home health orders during the global period in this "Coding Q&A" column.
ICD-10 ‘grace period’ ending soon, but don’t panic
By now, most of you are relatively fluent in the urology diagnosis codes that affect payment for the services provided in the urology office. Of course, we are now facing the end of the ICD-10 “grace period,” and fears of denials for bad diagnosis codes are once again starting to circulate. This begs the question, what should you do now?
T pellets: What are you allowed to charge?
In this "Coding Q&A" column, Ray Painter, MD, and Mark Painter also answer a question about how to code for cystoscopy with stent removal through the stoma in a patient with an ileal loop.
MIPS: A first look at how it will affect your practice
The Centers for Medicare & Medicaid Services (CMS) has released a proposed rule regarding the implementation of the Medicare Access and CHIP Reauthorization Act (MACRA) of 2015. This article will summarize some of the details of the proposed rule, including an outline of the Merit-Based Incentive Payment System (MIPS), one of the key components of MACRA.


View Results